Pfizer sues Johnson & Johnson over anti-competitive tactics
It claims J&J acted to squash its cheaper version of powerful rheumatoid arthritis drug
Washington
A LEGAL brawl between two of the world's largest drug companies could shape the future of a nascent market of copycat drugs that are intended to bring down the cost of the most advanced and expensive medicines.
Pfizer filed a lawsuit on Wednesday against fellow pharmaceutical giant Johnson & Johnson for using "anti-competitive" tactics to squash its cheaper version of a powerful rheumatoid arthritis drug.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO